{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T03:21:46Z","timestamp":1773285706765,"version":"3.50.1"},"reference-count":25,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2010,2,3]],"date-time":"2010-02-03T00:00:00Z","timestamp":1265155200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diabetes Obesity Metabolism"],"published-print":{"date-parts":[[2010,5]]},"abstract":"<jats:p>\n                    <jats:bold>Aim:<\/jats:bold>\n                    Postprandial release of intact proinsulin (IP) is an independent marker for\n                    <jats:italic>\u03b2<\/jats:italic>\n                    \u2010cell dysfunction in patients with type 2 diabetes. This open\u2010label, parallel\u2010group, two\u2010arm, pilot study compared the\n                    <jats:italic>\u03b2<\/jats:italic>\n                    \u2010cell protective effect of adding insulin glargine (GLA) vs. NPH insulin to ongoing metformin.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Material and methods:<\/jats:bold>\n                    Overall, 28 insulin\u2010naive type 2 diabetes subjects (mean \u00b1 SD age, 61.5 \u00b1 6.7 years; diabetes duration, 9.8 \u00b1 6.5 years; HbA1c, 7.1 \u00b1 0.5%; BMI, 30.7 \u00b1 4.3 kg\/m\n                    <jats:sup>2<\/jats:sup>\n                    ) treated with metformin and sulfonylurea were randomized to add once\u2010daily GLA or NPH at bedtime. At baseline and after 3 months, subjects received a standardized breakfast, lunch and dinner, with pre\u2010 and postprandial blood sampling to measure plasma IP, total insulin and blood glucose (BG).\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Results:<\/jats:bold>\n                    Insulin dose after 3 months was comparable in both groups (GLA vs. NPH: 23.6 \u00b1 13.4 vs. 23.3 \u00b1 12.7; p = NS ). Both treatments significantly reduced fasting BG levels (GLA: 158 \u00b1 19 to 121 \u00b1 23 mg\/dl; NPH: 156 \u00b1 34 to 119 \u00b1 29 mg\/dl; both p &lt; 0.01 vs. baseline). Fasting and postprandial BG levels did not differ between groups. IP levels decreased in both groups (p &lt; 0.05 at all timepoints). Although IP release after breakfast did not differ between treatments, GLA induced a greater reduction in IP release after lunch (p = 0.08) and dinner (p = 0.04). Total plasma insulin levels did not differ between groups.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Conclusions:<\/jats:bold>\n                    Adding basal insulin to metformin reduces postprandial\n                    <jats:italic>\u03b2<\/jats:italic>\n                    \u2010cell load. While GLA and NPH had comparable effects at breakfast, GLA reduces\n                    <jats:italic>\u03b2<\/jats:italic>\n                    \u2010cell stress more effectively at dinner, and with a trend at lunch, most probably because of its longer lasting pharmacodynamic profile.\n                  <\/jats:p>","DOI":"10.1111\/j.1463-1326.2010.01209.x","type":"journal-article","created":{"date-parts":[[2010,2,3]],"date-time":"2010-02-03T13:28:20Z","timestamp":1265203700000},"page":"437-441","source":"Crossref","is-referenced-by-count":15,"title":["Adding insulin glargine vs. NPH insulin to metformin results in a more efficient postprandial\n                    <i>\u03b2<\/i>\n                    \u2010cell protection in individuals with type 2 diabetes"],"prefix":"10.1111","volume":"12","author":[{"given":"T.","family":"Forst","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Larbig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Hohberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Forst","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Diessel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Borchert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.","family":"Roth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Pf\u00fctzner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2010,3,30]]},"reference":[{"key":"e_1_2_7_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(98)07019-6"},{"key":"e_1_2_7_3_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa066224"},{"key":"e_1_2_7_4_2","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.27.3.682"},{"key":"e_1_2_7_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9343(00)00336-3"},{"key":"e_1_2_7_6_2","first-page":"862","article-title":"Insulin sensitivity, proinsulin and insulin as predictors of coronary heart disease. A population\u2010based 10\u2010year, follow\u2010up study in 70\u2010year old men using the euglycaemic insulin clamp.","volume":"48","author":"Zethelius B","year":"2005","journal-title":"Int J Obes Relat Metab Disord"},{"key":"e_1_2_7_7_2","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.28.4.860"},{"key":"e_1_2_7_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2006.11.007"},{"key":"e_1_2_7_9_2","doi-asserted-by":"publisher","DOI":"10.5414\/CPP44014"},{"key":"e_1_2_7_10_2","doi-asserted-by":"publisher","DOI":"10.1507\/endocrj.47.763"},{"key":"e_1_2_7_11_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-0028-1119378"},{"key":"e_1_2_7_12_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-5491.1993.tb01992.x"},{"key":"e_1_2_7_13_2","doi-asserted-by":"publisher","DOI":"10.1089\/dia.2006.8.375"},{"key":"e_1_2_7_14_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00592-008-0078-z"},{"key":"e_1_2_7_15_2","first-page":"2229","article-title":"Beta cell dysfunction in patients with acute myocardial infarction but without previously known type 2 diabetes: a report from the GAMI study","volume":"48","author":"Wallander M","year":"2005","journal-title":"Int J Obes Relat Metab Disord"},{"key":"e_1_2_7_16_2","first-page":"597","article-title":"Polymorphisms in the TCF7L2, CDKAL1 and SLC30A8 genes are associated with impaired proinsulin conversion","volume":"51","author":"Kirchhoff K","year":"2008","journal-title":"Int J Obes Relat Metab Disord"},{"key":"e_1_2_7_17_2","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.51.2007.S234"},{"key":"e_1_2_7_18_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.STR.29.8.1498"},{"key":"e_1_2_7_19_2","doi-asserted-by":"publisher","DOI":"10.1159\/000110488"},{"key":"e_1_2_7_20_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-001-0756-7"},{"key":"e_1_2_7_21_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.STR.31.12.2936"},{"key":"e_1_2_7_22_2","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.15.5.666"},{"key":"e_1_2_7_23_2","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.49.12.2142"},{"key":"e_1_2_7_24_2","doi-asserted-by":"publisher","DOI":"10.1089\/152091504774198124"},{"key":"e_1_2_7_25_2","first-page":"567","article-title":"Intact and total proinsulin: new aspects for diagnosis and treatment of type 2 diabetes mellitus and insulin resistance","volume":"50","author":"Pfutzner A","year":"2004","journal-title":"Clin Lab"},{"key":"e_1_2_7_26_2","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.2337\/diab.43.12.1490","article-title":"Proinsulin and specific insulin concentration in high\u2010 and low\u2010risk populations for NIDDM","volume":"43","author":"Haffner SM","year":"1994","journal-title":"Diabetes"}],"container-title":["Diabetes, Obesity and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1463-1326.2010.01209.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/dom-pubs.pericles-prod.literatumonline.com\/doi\/pdf\/10.1111\/j.1463-1326.2010.01209.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T22:25:34Z","timestamp":1761863134000},"score":1,"resource":{"primary":{"URL":"https:\/\/dom-pubs.pericles-prod.literatumonline.com\/doi\/10.1111\/j.1463-1326.2010.01209.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,3,30]]},"references-count":25,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2010,5]]}},"alternative-id":["10.1111\/j.1463-1326.2010.01209.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1463-1326.2010.01209.x","archive":["Portico"],"relation":{},"ISSN":["1462-8902","1463-1326"],"issn-type":[{"value":"1462-8902","type":"print"},{"value":"1463-1326","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,3,30]]}}}